Biological Safety Cabinet Market - Size, Share, Industry Trends, and Forecasts (2023 - 2031)

Biological Safety Cabinet Market Dynamics - (DRO) :

Key Drivers :

Rising incidence of infectious as well as viral diseases

The rising cases of lethal infectious diseases is one of the prominent reasons fuelling the demand for the safety cabinets which is driving the expansion of the market across the globe. The fright of spreading infection from person to person, person to animal, animal to person, or animal to animal is one of the predominant factors driving the rigorous growth in the production of the cabinets. Incidences caused by Covid-19 and the Ebola virus have boosted the use of the cabinets in the medical sector. Analysis of market trends concludes that the increasing prevalence of infectious and viral diseases across the globe is driving the usage of the cabinets across healthcare facilities. For instance, according to the report by the World Health Organization in March 2023, about half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year. Thus, the growing incidences of viral and infectious diseases across the globe is driving the biological safety cabinet market demand.

Growing adoption of safety practices across pharmaceutical and biotechnology research laboratories

Biological safety cabinets are essential equipment in the biotechnology and pharmaceutical industries. They provide a safe and controlled environment for working with hazardous biological materials, such as bacteria, viruses, and other pathogens. BSCs protect laboratory workers from exposure to these materials, and they also prevent the spread of contamination to the surrounding environment. There is a significant increase in the knowledge and awareness of safety precautions among the research professionals. This has increased the probability of utilizing the cabinets during harmful research and diagnostic procedures. Researchers implies the importance of using them while executing clinical procedures. For instance, in June 2020, Biopharma installed 10 Premium 212 Microbiology Safety Cabinets to a gene therapy company in White City, London.

Furthermore, vaccine production as well as the manufacturing of pharmaceutical drugs have mandatory requirements of the cabinets, and several professionals suggest it as a necessary precaution. For instance, according to a Survey conducted by Central for Disease Control & Prevention, 73% of laboratory staff prefer taking precautions while working in the lab environment. Analysis of market trends concludes that the increasing awareness of safety measures and preference to work in a safe set-up is expected to drive the growth of the market.

Key Restraints :

High cost of cabinets

Biological safety cabinets are complex pieces of equipment that require careful design and construction to ensure that they meet the highest safety standards. The their main purpose is to protect medical equipment/professionals/devices, products, and environment from hazardous pollutants during routine procedures They must be able to protect laboratory workers from exposure to hazardous biological materials, and they must also prevent the spread of contamination to the surrounding environment. It is very important to use quality materials while preparing the safety cabinets. Various materials like HEPA filters and UV germicidal lamps are expensive and they increase the overall cost of the cabinets. This results into less business initiatives taken by companies and start-ups. Analysis of market trends concludes that the high cost of the cabinet lowers the adoption of the equipment across small scale companies and thus hinders the growth of the market.

Future Opportunities :

Growing investments in research and development activities across healthcare and pharmaceuticals sector

The demand for more convenient solutions for biological safety cabinets has motivated the increase in investment in research and development activities. There is also an increase in funding and grants allotted to manufacturing companies by government and private institutions for innovative alternatives to existing safety cabinets. For instance, in September 2023, The Indian government approved an investment of USD 72.08 million to 74 industries in the pharmaceutical and medical device manufacturing sectors. The investment was approved under the production-linked incentive (PLI) scheme. Furthermore, government initiatives like ‘Make in India', ‘Atmanirbhar Bharat Abhiyan', and ‘Start up India' by the Indian government has motivated several budding businesses across the country to come up with advanced solutions to replace traditional safety cabinets. Analysis of market trends concludes that the consistent demand to come up with innovative alternatives is is emerging as one of many biological safety cabinet market opportunities that will drive market expansion.